Epigenetic Silencing of OR and TAS2R Genes Expression in Human Orbitofrontal Cortex at Early Stages of Sporadic Alzheimer's Disease

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2023 Jul 5

PMID 37405535

Authors

Victoria Cunha Alves

Joana Figueiro-Silva

Isidre Ferrer

Eva Carro

Affiliations

Soon will be listed here.

Abstract

Modulation of brain olfactory (OR) and taste receptor (TASR) expression was recently reported in neurological diseases. However, there is still limited evidence of these genes' expression in the human brain and the transcriptional regulation mechanisms involved remain elusive. We explored the possible expression and regulation of selected OR and TASR in the human orbitofrontal cortex (OFC) of sporadic Alzheimer's disease (AD) and non-demented control specimens using quantitative real-time RT-PCR and ELISA. Global H3K9me3 amounts were measured on OFC total histone extracts, and H3K9me3 binding at each chemoreceptor locus was examined through native chromatin immunoprecipitation. To investigate the potential interactome of the repressive histone mark H3K9me3 in OFC specimens, native nuclear complex co-immunoprecipitation (Co-IP) was combined with reverse phase-liquid chromatography coupled to mass spectrometry analysis. Interaction between H3K9me3 and MeCP2 was validated by reciprocal Co-IP, and global MeCP2 levels were quantitated. We found that OR and TAS2R genes are expressed and markedly downregulated in OFC at early stages of sporadic AD, preceding the progressive reduction in their protein levels and the appearance of AD-associated neuropathology. The expression pattern did not follow disease progression suggesting transcriptional regulation through epigenetic mechanisms. We discovered an increase of OFC global H3K9me3 levels and a substantial enrichment of this repressive signature at ORs and TAS2Rs proximal promoter at early stages of AD, ultimately lost at advanced stages. We revealed the interaction between H3K9me3 and MeCP2 at early stages and found that MeCP2 protein is increased in sporadic AD. Findings suggest MeCP2 might be implicated in OR and TAS2R transcriptional regulation through interaction with H3K9me3, and as an early event, it may uncover a novel etiopathogenetic mechanism of sporadic AD.

Citing Articles

Genome-Wide DNA Methylation in Early-Onset-Dementia Patients Brain Tissue and Lymphoblastoid Cell Lines.

Ramos-Campoy O, Comas-Alberti A, Hervas D, Borrego-Ecija S, Bosch B, Sandoval J Int J Mol Sci. 2024; 25(10).

PMID: 38791483 PMC: 11121630. DOI: 10.3390/ijms25105445.

Olfactory Receptor OR2K2 Expression in Human Choroid Plexus as a Potential Marker in Early Sporadic Alzheimer's Disease.

Alves V, Figueiro-Silva J, Trullas R, Ferrer I, Carro E Genes (Basel). 2024; 15(3).

PMID: 38540444 PMC: 10970182. DOI: 10.3390/genes15030385.

References

Querfurth H, LaFerla F . Alzheimer's disease. N Engl J Med. 2010; 362(4):329-44. DOI: 10.1056/NEJMra0909142. View

Braak H, Braak E . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991; 82(4):239-59. DOI: 10.1007/BF00308809. View

Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K . Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006; 112(4):389-404. PMC: 3906709. DOI: 10.1007/s00401-006-0127-z. View

Zhong S, Zhang S, Fan X, Wu Q, Yan L, Dong J . A single-cell RNA-seq survey of the developmental landscape of the human prefrontal cortex. Nature. 2018; 555(7697):524-528. DOI: 10.1038/nature25980. View

Nestor P, Nakamura M, Niznikiewicz M, Thompson E, Levitt J, Choate V . In search of the functional neuroanatomy of sociality: MRI subdivisions of orbital frontal cortex and social cognition. Soc Cogn Affect Neurosci. 2012; 8(4):460-7. PMC: 3624957. DOI: 10.1093/scan/nss018. View

Catani M, DellAcqua F, Thiebaut de Schotten M . A revised limbic system model for memory, emotion and behaviour. Neurosci Biobehav Rev. 2013; 37(8):1724-37. DOI: 10.1016/j.neubiorev.2013.07.001. View

Pluznick J, Caplan M . Novel sensory signaling systems in the kidney. Curr Opin Nephrol Hypertens. 2012; 21(4):404-9. DOI: 10.1097/MNH.0b013e328354a6bd. View

Garcia-Esparcia P, Schluter A, Carmona M, Moreno J, Ansoleaga B, Torrejon-Escribano B . Functional genomics reveals dysregulation of cortical olfactory receptors in Parkinson disease: novel putative chemoreceptors in the human brain. J Neuropathol Exp Neurol. 2013; 72(6):524-39. DOI: 10.1097/NEN.0b013e318294fd76. View

Grison A, Zucchelli S, Urzi A, Zamparo I, Lazarevic D, Pascarella G . Mesencephalic dopaminergic neurons express a repertoire of olfactory receptors and respond to odorant-like molecules. BMC Genomics. 2014; 15:729. PMC: 4161876. DOI: 10.1186/1471-2164-15-729. View

10.

Ansoleaga B, Garcia-Esparcia P, Llorens F, Moreno J, Aso E, Ferrer I . Dysregulation of brain olfactory and taste receptors in AD, PSP and CJD, and AD-related model. Neuroscience. 2013; 248:369-82. DOI: 10.1016/j.neuroscience.2013.06.034. View

11.

Ansoleaga B, Garcia-Esparcia P, Pinacho R, Haro J, Ramos B, Ferrer I . Decrease in olfactory and taste receptor expression in the dorsolateral prefrontal cortex in chronic schizophrenia. J Psychiatr Res. 2014; 60:109-16. DOI: 10.1016/j.jpsychires.2014.09.012. View

12.

Wiener A, Shudler M, Levit A, Niv M . BitterDB: a database of bitter compounds. Nucleic Acids Res. 2011; 40(Database issue):D413-9. PMC: 3245057. DOI: 10.1093/nar/gkr755. View

13.

Duarte A, Santos J, Costa A, Ferreira C, Tomas J, Quintela T . Bitter taste receptors profiling in the human blood-cerebrospinal fluid-barrier. Biochem Pharmacol. 2020; 177:113954. DOI: 10.1016/j.bcp.2020.113954. View

14.

Tomas J, Santos C, Quintela T, Goncalves I . "Tasting" the cerebrospinal fluid: Another function of the choroid plexus?. Neuroscience. 2016; 320:160-71. DOI: 10.1016/j.neuroscience.2016.01.057. View

15.

Ren X, Zhou L, Terwilliger R, Newton S, de Araujo I . Sweet taste signaling functions as a hypothalamic glucose sensor. Front Integr Neurosci. 2009; 3:12. PMC: 2706652. DOI: 10.3389/neuro.07.012.2009. View

16.

Lagerstrom M, Schioth H . Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov. 2008; 7(4):339-57. DOI: 10.1038/nrd2518. View

17.

Duarte A, Costa A, Goncalves I, Quintela T, Preissner R, Santos C . The druggability of bitter taste receptors for the treatment of neurodegenerative disorders. Biochem Pharmacol. 2022; 197:114915. DOI: 10.1016/j.bcp.2022.114915. View

18.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

19.

Jorge I, Casas E, Villar M, Ortega-Perez I, Lopez-Ferrer D, Martinez-Ruiz A . High-sensitivity analysis of specific peptides in complex samples by selected MS/MS ion monitoring and linear ion trap mass spectrometry: application to biological studies. J Mass Spectrom. 2007; 42(11):1391-403. DOI: 10.1002/jms.1314. View

20.

Mi H, Muruganujan A, Huang X, Ebert D, Mills C, Guo X . Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0). Nat Protoc. 2019; 14(3):703-721. PMC: 6519457. DOI: 10.1038/s41596-019-0128-8. View